ENDRA Life Sciences (NDRA) Return on Assets (2017 - 2026)

ENDRA Life Sciences (NDRA) has 10 years of Return on Assets data on file, last reported at 0.02% in Q1 2026.

• Return on Assets for Q1 2026 came in at 0.02%, up 1.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.02% (up 1.0% YoY), and the FY2025 annual result was 0.02%, changed 0.0% from the prior year.
• Return on Assets grew to 0.02% in Q1 2026 per NDRA's latest filing, from 0.02% in the prior quarter.
• Over five years, Return on Assets peaked at 0.01% in Q2 2022 and troughed at 0.03% in Q3 2025.
• A 5-year average of 0.02% and a median of 0.02% in 2023 frame the typical range for Return on Assets.
• The sharpest annual moves came in 2025 and 2026: Return on Assets declined 2 bps in 2025, then rose 1 bps in 2026.
• A 5-year view of Return on Assets shows it stood at 0.01% in 2022, then dropped by 15 bps to 0.01% in 2023, then slipped by 28 bps to 0.02% in 2024, then plunged by 35 bps to 0.02% in 2025, then grew by 17 bps to 0.02% in 2026.
• Business Quant data shows NDRA's Return on Assets at 0.02% in Q1 2026, 0.02% in Q4 2025, and 0.03% in Q3 2025.